About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Breast Cancer Research and Treatment
›
Top Articles
Breast Cancer Research and Treatment
Oncology
4.4
(top 3%)
Impact Factor
4.8
(top 3%)
extended IF
173
(top 1%)
H-Index
6.8K
authors
10.1K
papers
335.3K
citations
8.5K
citing journals
106.6K
citing authors
Most Cited Articles of Breast Cancer Research and Treatment
Title
Year
Citations
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2010
1.9K
The Nottingham Prognostic Index in primary breast cancer
1992
792
Epidemiology of basal-like breast cancer
2008
651
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
2010
638
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
2008
631
REporting recommendations for tumor MARKer prognostic studies (REMARK)
2006
604
Relevance of breast cancer cell lines as models for breast tumours: an update
2004
602
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
1992
596
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
1995
578
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation
2001
539
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
2011
533
Differentiation of the mammary gland and susceptibility to carcinogenesis
1982
532
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
2016
507
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen
2007
470
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
2008
425
Breast cancer survivors: psychosocial concerns and quality of life
1996
418
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
2008
417
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database
2002
408
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012
383
Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen
2004
378
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
2014
375
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine
2010
372
Role of epidermal growth factor receptor in breast cancer
2012
371
Pattern of metastatic spread in triple-negative breast cancer
2009
369
The role of vascular endothelial growth factor in pathological angiogenesis
1995
363
previous
1996
1997
1998
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.